| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/02/2005 | EP1502603A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM Fc gamma RIIIa POLYMORPHISM |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501866A2 Apo-2 ligand variants and uses thereof |
| 02/02/2005 | EP1501834A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501833A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501830A1 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 02/02/2005 | EP1501829A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |
| 02/02/2005 | EP1501803A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 02/02/2005 | EP1501801A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/02/2005 | EP1501797A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501796A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501794A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501566A1 Medical products comprising a haemocompatible coating, production and use thereof |
| 02/02/2005 | EP1501565A1 Compounds and method for coating surfaces in a haemocompatible manner |
| 02/02/2005 | EP1501550A1 Non-viral gene delivery system |
| 02/02/2005 | EP1501545A2 Use of tnfalpha antibodies and another drug |
| 02/02/2005 | EP1501543A1 Use of modified novirhabdoviruses to obtain vaccines |
| 02/02/2005 | EP1501537A1 Mannose binding lectin and uses thereof |
| 02/02/2005 | EP1501525A1 Method for producing preparations rich in tocotrienol |
| 02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
| 02/02/2005 | EP1501512A2 4-azasteroid derivatives as androgen receptor modulators |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1501507A2 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 02/02/2005 | EP1501505A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -t riazole for the treatment of autoimmune diseases |
| 02/02/2005 | EP1501504A1 1-substituted imidazole derivatives as nos inhibitors |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | EP1501359A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 02/02/2005 | EP1440161A4 7118, a human arginine n-methyltransferase family member and uses therefor |
| 02/02/2005 | EP1363642A4 Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion |
| 02/02/2005 | EP1362050B1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 02/02/2005 | EP1343512B1 Injectable solution with anti-inflammatory effect and process for manufacturing the same |
| 02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
| 02/02/2005 | EP1221490B1 Recombinant adenoviral vectors and their utilization in the treatment of liver cirrhosis |
| 02/02/2005 | EP1184376B1 Novel heterocyclic carboxamide derivatives |
| 02/02/2005 | EP1161235B1 Combinations for the treatment of diseases involving angiogenesis |
| 02/02/2005 | EP1124779B1 Vitamin d analogues |
| 02/02/2005 | EP1025079B1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 02/02/2005 | EP0851769B1 Gene therapy using ovine adenoviral vectors |
| 02/02/2005 | EP0832227B1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 02/02/2005 | EP0761683B1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575184A Method and composition for treating immune complex associated disorders |
| 02/02/2005 | CN1575179A Combination product comprising melagatran and dexamethasone |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575174A Pharmaceutically active isoindoline derivatives |
| 02/02/2005 | CN1575173A Macrolides containing pharmaceutical compositions |
| 02/02/2005 | CN1575163A Granule formulation |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572325A Treatment of lupus nephritis with anti-CD40L compounds |
| 02/02/2005 | CN1572324A Adjuvant composition |
| 02/02/2005 | CN1572317A Anti-allergic traditional Chinese medicine composition and preparing method thereof |
| 02/02/2005 | CN1187442C Method for transferring antigens to dendritic cells |
| 02/02/2005 | CN1187374C Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/02/2005 | CN1187094C Polyol-IFN-beta conjugates |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/02/2005 | CN1187062C Chinese medicine preparation for curing hematopathy |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/02/2005 | CN1187045C Substances for use in treating psoriasis |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849725 Single-stranded, dumbbell-shaped DNA as immunostimulants, immunomodulators |
| 02/01/2005 | US6849663 Particularly septic shock |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 02/01/2005 | US6849631 Semicarbazides and their uses |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849624 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 02/01/2005 | US6849452 Bringing an enriched population of resting NK cells into contact with mature or triggered dendritic cells in vitro or ex vivo, under conditions allowing activation of such resting NK cells by mature or triggered cells |
| 02/01/2005 | US6849451 Hybrid cells |
| 02/01/2005 | US6849446 Genetic engineering |
| 02/01/2005 | US6849427 Dermatophagoides pteronyssinus proteins |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 02/01/2005 | US6849260 Methods and compositions for treating IgE-related disease using NNT-1 inhibitors |
| 02/01/2005 | US6849058 Treating rheumatoid arthritis by administering a photoactive compound such as a porphyrin systemically, directly to an affected joint or extracorporally to blood and irradiating to effect activation; returning blood to body |
| 02/01/2005 | CA2183976C Process for making an epoxide |
| 02/01/2005 | CA2166326C Pyridazinone derivatives |
| 01/27/2005 | WO2005007700A1 Antibodies to cd44 vra and methods of use |
| 01/27/2005 | WO2005007699A2 Human antibody molecules for il-13 |
| 01/27/2005 | WO2005007667A1 Curcuminoid glycoside and process for producing the same |
| 01/27/2005 | WO2005007616A1 Diphenylamino ketone derivatives as mek inhibitors |
| 01/27/2005 | WO2005007190A1 Agonists or antagonists of the clucocorticoid-induced tumour necrosis factor receptor (gitr) or its ligand for the treatment of immune disorders, infections and cancer |
| 01/27/2005 | WO2005007145A1 Pharmaceutical product comprising a beta-2 adrenoceptor agonist and an antihistamine |